Article Information
- Received June 14, 2016
- Revision received July 8, 2016
- Accepted August 5, 2016
- First published September 21, 2016.
- Version of record published September 21, 2016.
Author Information
Author contributions
Author contributions: T.S., S.H., and T.C.S. designed research; T.S., Y.M., N.Y., and T.C.S. performed research; T.S., Y.M., N.Y., and T.C.S. contributed unpublished reagents/analytic tools; T.S., Y.M., N.Y., and T.C.S. analyzed data; T.C.S. wrote the paper.
Disclosures
- Received June 14, 2016.
- Revision received July 8, 2016.
- Accepted August 5, 2016.
This work was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (T.S.); the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (T.S.); and the Brain Mapping by Integrated Neurotechnologies for Disease Studies project of the Japan Agency for Medical Research and Development (T.C.S.). We thank Kazuhiro Yamakawa for providing antibodies to Nav1.1 and Charles Yokoyama for editing this manuscript.
T.S., Y.M., and T.C.S. serve as advisor, director, and CEO, respectively, for RIKEN BIO Co. Ltd., a RIKEN venture based at the Brain Science Institute, Central Building, Wako, Japan.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
- Correspondence should be addressed to Takaomi C. Saido at the above address. saido{at}brain.riken.jp
Online Impact